Many physicians and practices say prior authorization is a major administrative burden and have urged lawmakers to institute reforms to the process for commercial and public payers.
Cedars-Sinai experts are advocating for patients to have access to GLP-1 medications such as semaglutide as a key component to caring for and preventing cardiovascular disease.
Sources told CNBC’s David Faber that a private equity firm’s prospective deal to acquire Walgreens Boots Alliance is “mostly dead,” The Wall Street Journal reported Jan. 27.
Anesthesia providers are in the process of transitioning to value-based care reimbursement systems and pushing for inclusion in innovative models supported by CMS, according to a Jan. 24 report from law firm Whiteford in JDSupra.